BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $621,000 | -3.1% | 4,108 | -6.7% | 0.06% | -1.6% |
| Q2 2022 | $641,000 | +22.8% | 4,401 | -0.1% | 0.06% | +90.9% |
| Q1 2022 | $522,000 | -12.7% | 4,406 | +1.6% | 0.03% | -10.8% |
| Q4 2021 | $598,000 | +95.4% | 4,336 | +97.1% | 0.04% | +76.2% |
| Q3 2021 | $306,000 | +43.0% | 2,200 | 0.0% | 0.02% | +50.0% |
| Q2 2021 | $214,000 | +2040.0% | 2,200 | +1366.7% | 0.01% | +1300.0% |
| Q3 2020 | $10,000 | -9.1% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +120.0% | 150 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |